The natural history of early prostate cancer and the impact of endocrine treatment, J. Adolfsson; early versus deferred hormone therapy, J. Anderson; a review of studies of hormonal adjuvant therapy in prostate cancer, M. Wirth and M. Froehner; quality of life issues relating to endocrine treatment options, P. Iversen; the future of endocrine treatment in early prostate cancer - concluding remarks, F.H. Schroder.